Medicare
- Blog Post
Upcoming Presentations by Staff of CBO’s Health Analysis Division
This summer, analysts in CBO's Health Analysis Division will present their work in three sessions at the 14th Annual Conference of the American Society of Health Economists (ASHEcon) in Nashville, Tennessee.
- Report
Potential Statutory Pay-As-You-Go Effects of a Bill to Provide Reconciliation Pursuant to H. Con. Res. 14, the One Big Beautiful Bill Act
CBO responds to questions concerning the sequestration (cancellation of budgetary resources) that would occur under the Statutory Pay-As-You-Go Act of 2010 if an enacted bill raised deficits by $2.3 trillion over 10 years.
- Presentation
The Federal Perspective on Coverage of Medications to Treat Obesity: Considerations From the Congressional Budget Office
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop on GLP-1-Based Therapies.
- Report
The Long-Term Budget Outlook: 2025 to 2055
Extending the 10-year budget projections it published on January 17, 2025, CBO projects that federal debt held by the public, boosted by sustained deficits, will grow far beyond any previously recorded level over the next 30 years.
- Report
The Budget and Economic Outlook: 2025 to 2035
In CBO’s projections, the federal budget deficit is $1.9 trillion this year, and federal debt rises to 118 percent of GDP in 2035. Economic growth slows and inflation declines over the next two years; both remain moderate after 2026.
- Report
How Increased Use of Gene Therapy Treatment for Sickle Cell Disease Could Affect the Federal Budget
Gene therapies replace or modify disease-causing genes in human cells. In this report, CBO discusses how it would estimate the budgetary effects of policies that sought to increase the use of gene therapy treatment for sickle cell disease.
- Report
Options for Reducing the Deficit: 2025 to 2034
CBO periodically issues a compendium of policy options and their estimated effects on the federal budget. This report presents 76 options for altering spending or revenues to reduce federal budget deficits over the next decade.
- Report
How Would Authorizing Medicare to Cover Anti-Obesity Medications Affect the Federal Budget?
CBO estimates the budgetary effects of an illustrative policy that would authorize Medicare to cover anti-obesity medications. The policy would apply to all beneficiaries with obesity and some beneficiaries who are classified as overweight.
- Report
Alternative Approaches to Reducing Prescription Drug Prices
CBO discusses prescription drug prices and approaches aimed at reducing those prices. Some of the approaches would cap prices or limit their growth, and other approaches would promote price competition or affect the flow of information.
- Report
Part 2 of Answers to Questions for the Record Following a Hearing on An Update to the Budget and Economic Outlook: 2024 to 2034
The Senate Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified. This document provides CBO’s answers to 18 of the 29 questions submitted for the record.